Community-based Implementation of Online EmReg
Launched by ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · Jun 27, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a program called Online EmReg, which helps people with Traumatic Brain Injury (TBI) manage their emotions better. The main goal of the trial is to find out the best way to train mental health professionals, like psychologists and counselors, to deliver this online program effectively. Researchers will compare two training methods: one is a standard 3-hour workshop, and the other includes the same workshop plus additional support over three months. They will look at how these training methods affect the care that patients receive and whether patients show improvements in managing their emotions.
To participate in the trial, mental health professionals must have experience working with TBI patients and providing group therapy, and they need to be trained in a type of therapy called Cognitive Behavioral Therapy (CBT). Participants should also be comfortable using telehealth technology to conduct online treatment sessions. The trial is currently recruiting, and those who join can expect to be involved for up to 15 months, during which their training experience and the progress of their patients will be evaluated through surveys and role-plays.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Licensed psychologist, social worker, or mental health counselor.
- • Training and experience in CBT, the framework for EmReg.
- • Experience working with people with TBI.
- • Experience providing group treatment.
- • A computer and internet to conduct group treatment via telehealth.
- • Actively treating ≥3 patients with TBI who are appropriate for EmReg (have emotion regulation difficulties based on clinician assessment).
- • Amenable to study tasks (e.g., completion of training, consultation, performance based role-play, data collection).
- • Not previously trained in EmReg.
- • Proficient in English.
- Exclusion Criteria:
- • Not willing to conduct group treatment via telehealth.
- • Non-English speaking.
About Icahn School Of Medicine At Mount Sinai
The Icahn School of Medicine at Mount Sinai is a premier academic institution located in New York City, renowned for its commitment to advancing medical research, education, and patient care. As a leading sponsor of clinical trials, the institution leverages its state-of-the-art facilities and multidisciplinary expertise to drive innovative research initiatives aimed at improving health outcomes. With a focus on translational medicine, the Icahn School of Medicine collaborates with a diverse network of researchers, clinicians, and industry partners to explore novel therapies and interventions across a wide range of medical disciplines. Its rigorous scientific approach and dedication to ethical standards position it as a trusted leader in the clinical research landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New York, New York, United States
Patients applied
Trial Officials
Maria Kajankova, PhD
Principal Investigator
Icahn School of Medicine at Mount Sinai
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported